| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |